Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CLOV — Clover Health Investments, Corp. /De

CIK 1423053 MIAMI, FL
Back to CLOV Full portfolio

Position in CLOV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,335,194
+$8,029,830 QoQ
Shares Held
2,163,205
+15.2% QoQ
Ownership
0.407%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 224 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLOV Over Time

Shares Held

Position Value (USD)

Derivatives in CLOV

reported options exposure · as of Jun 30, 2026
CallValue
$5,373,096
CallShares
1,025,400
PutValue
$6,236,124
PutShares
1,190,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Healthcare Plans

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,815,524,919 across 10 Healthcare Plans names. CLOV ranks #9 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CVS
CVS HEALTH Corp
 4,812,530 $497,856,227
2 UNH
Unitedhealth Group Inc
 1,064,151 $442,293,079
3 ELV
Elevance Health, Inc.
 906,386 $350,526,656
4 HUM
Humana Inc
 449,022 $178,360,518
5 OSCR
Oscar Health, Inc.
 4,229,552 $120,626,822
6 CI
Cigna Group
 321,435 $88,613,200
7 CNC
Centene Corp
 1,007,326 $64,660,254
8 PGNY
Progyny, Inc.
 1,785,717 $51,482,220

All Filings in CLOV

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,335,194 2,163,205
2026-06-30 $6,236,124 1,190,100
2026-06-30 $5,373,096 1,025,400
2026-03-31 $810,304 460,400
2026-03-31 $3,305,364 1,878,048
2026-03-31 $1,791,328 1,017,800
2025-12-31 $3,085,550 1,313,000
2025-12-31 $1,310,360 557,600
2025-12-31 $2,697,659 1,147,940
2025-09-30 $3,183,318 1,040,300
2025-09-30 $3,430,260 1,121,000
2025-09-30 $4,552,209 1,487,650
2025-06-30 $9,849,734 3,530,371
2025-06-30 $2,463,849 883,100
2025-06-30 $2,640,456 946,400
2025-03-31 $6,225,113 1,734,015
2025-03-31 $1,835,926 511,400
2025-03-31 $3,540,458 986,200
2024-12-31 $2,353,995 747,300
2024-12-31 $2,870,604 911,303
2024-12-31 $2,411,640 765,600
2024-09-30 $405,653 143,849
2024-09-30 $2,774,034 983,700
2024-09-30 $3,171,654 1,124,700
2024-06-30 $465,555 378,500
2024-06-30 $2,034,178 1,653,804
2024-06-30 $719,673 585,100
2024-03-31 $161,499 203,400
2024-03-31 $26,791 33,742
2024-03-31 $416,214 524,200
2023-12-31 $419,260 440,400
2023-12-31 $388,416 408,000
2023-12-31 $127,495 133,924
2023-09-30 $3,804,167 3,522,377
2023-09-30 $493,668 457,100
2023-09-30 $422,820 391,500
2023-06-30 $301,661 336,300
2023-06-30 $265,153 295,600
2023-06-30 $4,797,400 5,348,273
2023-03-31 $366,138 433,300
2023-03-31 $332,845 393,900
2023-03-31 $1,581,680 1,871,812
2022-12-31 $1,793,846 1,928,867
2022-12-31 $771,621 829,700
2022-12-31 $1,079,265 1,160,500
2022-09-30 $912,560 536,800
2022-09-30 $1,033,954 608,209
2022-09-30 $813,450 478,500
2022-06-30 $2,814,314 1,315,100
2022-06-30 $1,034,476 483,400

Report a Problem

Category
Description
Email (optional, for follow-up)